The US Food and Drug Administration, (FDA) has approved a drug combination for initial treatment of patients with advanced renal cell carcinoma, the most common type of kidney cancer. This follows the FDA’s priority review of the results of a Phase 3 trial of combination of Merck Research Laboratories drug Keytruda with Pfizer’s Inlyta. Keytruda…
The latest NHS statistics for UK show that 9% of boys and 12% of girls aged between 2 and 4 are obese. This percentage rises alarmingly to 25% of boys and 26% of girls aged 13 to 15. If you include statistics for childhood overweight, the percentages almost double. These trends are mirrored in…
A US jury has decided that a weed killer containing glyphosate caused a man’s cancer. The herbicide is produced by German-based pharmaceuticals firm Bayer AG and this is the second US case against the company regarding the weed killer Roundup, produced initially by US firm Monsanto which was recently bought by Bayer. The firm claims…
NHS England data for January 2019 show that no less than one in four patients diagnosed with cancer did not start treatment on time, Hospitals have a target of 85% of patients starting treatment for Cancer within 62 days of their GP’s urgent referral. This is not being met because of lack of hospital…